Menu

Federal Contractor Misconduct Database (FCMD)

The federal government routinely awards contracts to companies with histories of misconduct, including contract fraud and other violations. POGO believes that providing this website will help to improve contracting decisions and increase public knowledge of how the government spends billions of taxpayer dollars each year. Read more…

Illegal Marketing of Genotropin

In 2007, Pfizer subsidiaries Pharmacia & Upjohn Company, Inc., and Pharmacia & Upjohn Company, LLC paid $34.7 million to resolve charges stemming from the off-label marketing of Genotropin — a human growth hormone medicine — and the inappropriate use of a vendor contract to increase the sales of other Pharmacia medicines. Both settlements cover activities that occurred at Pharmacia before that company was acquired by Pfizer in 2003. Pharmacia & Upjohn Company Inc. also pleaded guilty to a single count of offering to an outside vendor remuneration in the form of an award of a contract to manage a Genotropin patient assistance program as an inducement for recommending the purchase of Pharmacia medicines. Pharmacia & Upjohn Company LLC and Pfizer Inc. also entered into a Deferred Prosecution Agreement and a Non-Prosecution Agreement, respectively, with the Department of Justice.

Misconduct Type
Health
Enforcement Agency
Multiple Agencies
Contracting Party
None
Court Type
Criminal
Disposition
Pleaded Guilty
Date of Announcement
4/2/2007
Contractors Involved Penalty
Total
Pfizer, Inc. $34,700,000
Further Information Released
Pfizer Non-Prosecution Agreement 2/13/2014
Pfizer Press Release 3/25/2010
Pharmacia Deferred Prosecution Agreement 3/25/2010

Federal Contractor Misconduct Database